Curis, Inc. (CRIS) financial statements (2022 and earlier)

Company profile

Business Address 128 SPRING STREET
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1401832124604582
Cash and cash equivalents401301524382633
Short-term investments763951221849
Other undisclosed cash, cash equivalents, and short-term investments2415(0)0(0)0 
Restricted cash and investments  0    
Receivables3333322
Other undisclosed current assets(21)(13)11111
Total current assets:1221732528644886
Noncurrent Assets
Operating lease, right-of-use asset670
Property, plant and equipment1100000
Long-term investments and receivables2415     
Long-term investments2415     
Intangible assets, net (including goodwill)9999999
Goodwill9999999
Restricted cash and investments1110000
Other noncurrent assets 000000
Total noncurrent assets:403210910109
TOTAL ASSETS:1622043537745895
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities13866896
Accounts payable6443564
Accrued liabilities6423332
Debt 107655
Other undisclosed current liabilities12 (0)   
Total current liabilities:1310713141411
Noncurrent Liabilities
Long-term debt and lease obligation45 29361520
Long-term debt, excluding current maturities   29361520
Operating lease, liability45 
Liabilities, other than long-term debt 0 0000
Other liabilities 0 0000
Other undisclosed noncurrent liabilities495862    
Total noncurrent liabilities:58646229361520
Total liabilities:72746942502830
Stockholders' equity
Stockholders' equity attributable to parent91131(34)(4)242965
Common stock1100211
Treasury stock, value    (2)(2)(2)
Additional paid in capital1,1821,177983980976928903
Accumulated other comprehensive income (loss)(0)(0)  (0)(0)0
Accumulated deficit(1,092)(1,047)(1,017)(985)(952)(899)(839)
Total stockholders' equity:91131(34)(4)242965
TOTAL LIABILITIES AND EQUITY:1622043537745895

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues111110101088
Revenue, net1088
Gross profit:111110101088
Operating expenses(53)(36)(34)(40)(60)(66)(64)
Operating loss:(42)(25)(24)(29)(50)(58)(56)
Nonoperating expense(3)(5)(8)(3)(4)(2)(3)
Other nonoperating income (expense)10(0)(3)(4)(2)(3)
Interest and debt expense  (3)(4)(4)(3)(3)
Net loss:(45)(30)(36)(37)(57)(63)(62)
Other undisclosed net income attributable to parent  34433
Net loss available to common stockholders, diluted:(45)(30)(32)(33)(53)(60)(59)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(45)(30)(36)(37)(57)(63)(62)
Comprehensive loss:(45)(30)(36)(37)(57)(63)(62)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)34433
Comprehensive loss, net of tax, attributable to parent:(46)(30)(32)(33)(53)(60)(59)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: